Daniel A Ermann

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Palliative Care

Top Venues

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Victoria A Vardell, Daniel A Ermann, Lindsey Fitzgerald, Harsh R Shah, Boyu Hu, Deborah M Stephens
T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments. American journal of hematology 99 (3) (2024)
Victoria A Vardell, Daniel A Ermann, Lindsey Fitzgerald, Harsh R Shah, Boyu Hu, Deborah M Stephens
T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments. American journal of hematology 99 (3) (2024)
Victoria A Vardell, Daniel A Ermann, Lindsey Fitzgerald, Harsh R Shah, Boyu Hu, Deborah M Stephens
T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments. American journal of hematology (2024)
Victoria A Vardell, Daniel A Ermann, Lindsey Fitzgerald, Harsh R Shah, Boyu Hu, Deborah M Stephens
T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments. American journal of hematology 99 (3) (2024)
Victoria A Vardell, Daniel A Ermann, Lindsey A Fitzgerald, Harsh R Shah, Boyu Hu, Deborah M Stephens
Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia. American journal of hematology (2023)
Ajay Major, Edward Robert Scheffer Cliff, Daniel A Ermann, Urshila Durani, David A Russler-Germain
Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions. EJHaem 3 (3) (2022)
Victoria A Vardell, Daniel A Ermann, Srinivas K Tantravahi, Benjamin Haaland, Brian McClune, Amandeep Godara, Ghulam Rehman Mohyuddin, Douglas W Sborov
Impact of academic medical center access on outcomes in multiple myeloma. American journal of hematology (2022)